Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Rio Tinto (ADR) (RIO) Price & Performance

Halozyme Therapeutics Inc. Common StockTrade
Rio Tinto (ADR)Trade

Price performance (Past 24H)

Key statistics

Halozyme Therapeutics Inc. Common Stock vs Rio Tinto (ADR) — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Rio Tinto (ADR) trades at $94.78 (market cap $150.89B). The key difference: Rio Tinto (ADR) is far larger — about 12× Halozyme Therapeutics Inc. Common Stock's market cap, and Rio Tinto (ADR) pays a 4.98% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Rio Tinto (ADR) for 10 Days on average.

HALORIO
Market Cap
$12.58B$150.89B
Volume
2,179,2781,492,444
Sector
HealthBasic Materials
52-Week High
$115.22$112.04
52-Week Low
$61.63$65.44
Typical Hold Time
1 Days10 Days
Enterprise Value
$14.49B$164.24B
Dividend Yield
—4.98%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HALO

No sentiment data available yet.

RIO
100% Buy0% Sell
Avg holding period · 10 Days

Top news

Latest headlines on both assets

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →

About Rio Tinto (ADR)

Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.

Read more on RIO →